These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 17655695)

  • 1. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
    Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
    J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.
    Cruciani M; Mengoli C; Serpelloni G; Mazzi R; Bosco O; Malena M
    Vaccine; 2007 Jan; 25(4):709-18. PubMed ID: 16963165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on rhGM-CSF as adjuvant in revaccination among adults of non-and hyporesponders to hepatitis B vaccine].
    Chen HX; Wang XY; Wang SQ; He HT; Luo XG; Chen XG; Lin CS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):177-9. PubMed ID: 20104770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
    Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults.
    Hasan MS; Agosti JM; Reynolds KK; Tanzman E; Treanor JJ; Evans TG
    J Infect Dis; 1999 Dec; 180(6):2023-6. PubMed ID: 10558962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune effects of three different programs for revaccination among adults of non- and hypo-responders to hepatitis B vaccine].
    Lin CS; Wang XY; Chen HX; Lee WH; He HT; Gao ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):37-40. PubMed ID: 19534878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM; Tabatabaei SV
    Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte macrophage colony stimulating factor augmented hepatitis B vaccine protocol for rapid seroprotection in voluntary kidney donors.
    Krishnamurthy K; John GT; Abraham P; Jacob CK
    Indian J Med Res; 2004 Apr; 119(4):162-4. PubMed ID: 15147122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.
    Aziz A; Aziz S; Li DS; Murphy L; Leone N; Kennedy M; Dhillon S; Van Thiel DH
    J Viral Hepat; 2006 Apr; 13(4):217-21. PubMed ID: 16611186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
    Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
    Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprotection after hepatitis B vaccination in chronic kidney disease patients with modified schedule and dosage.
    Siddiqui S; Malik A; Shukla I; Rizvi M; Haque SF
    J Infect Dev Ctries; 2010 Jun; 4(6):389-92. PubMed ID: 20601791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
    J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.